Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTOLEOS: Tolerability, Adherence and Efficacy of Protelos 2 g in Postmenopausal Osteoporosis
2005-004986-41Phase 4Completed
- Sponsor
- Servier
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of strontium ranelate in postmenopausal osteoporosis, sponsored by Servier. Primary endpoints: Treatment adherence (compliance and persistence) and Quality of life and back pain. Started Oct 2005; status: completed.
02
Drugs
strontium ranelate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on 2005-004986-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004986-41.